Associate Professor of Surgery with tenure Duke University Medical Center Durham, North Carolina, United States
Disclosure(s):
Georgia M. Beasley, MD MHS: Asana BioSciences, LLC; Bristol-Myers Squibb; Merck & Co., Inc.; Novartis Pharmaceuticals Corporation; and Replimune Group Inc: Research Grant (Terminated, September 13, 2023), Speaker (Terminated, September 13, 2023)
This Melanoma CME session will cover some contemporary challenges facing those in clinical practice today, namely, how to improve access to care in patients who are in rural communities, understanding the options for treatment for recurrent melanoma and understanding the new landscape for the use of neoadjuvant immunotherapy for clinically advanced, but resectable melanoma.
